 ThirdAge |
FDA Okays Byetta Plus Insulin Glargine
MedPage Today WASHINGTON — The FDA has approved a new indication for the type 2 diabetes drug exenatide (Byetta) as an add-on therapy with insulin glargine, diet, and exercise for adult patients. … Byetta Receives Expanded Approval from FDA, as Reported by DiabeticLive.comSan Francisco Chronicle (press release) FDA approves Byetta as insulin glargine add-onClinical Advisor Byetta (exenatide) Approved In Combination With Glargine For Type 2 DiabetesMedical News Today ThirdAge –Endocrine Today –Wall Street Journal all 58 news articles » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.